[{"_id":"5562fd3cee6e1634eb0601b4","決算期":"2015年3月期","証券コード":"4526","会社名":"理研ビタミン(株)【4526】","会計方式":"日本方式","決算発表日":"2015年4月27日","決算月数":"12か月","売上高":"85,603百万円","営業利益":"4,651百万円","経常利益":"4,685百万円","当期利益":"3,795百万円","EPS（一株当たり利益）":"171.67円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"3,413.40円","総資産":"114,095百万円","自己資本":"75,477百万円","資本金":"2,537百万円","有利子負債":"13,318百万円","自己資本比率":"66.2%","ROA（総資産利益率）":"3.51%","ROE（自己資本利益率）":"5.34%","総資産経常利益率":"4.33%","日付":"2015-05-31T15:09:02.339Z"},{"_id":"5562fd3cee6e1634eb0601b5","決算期":"2014年3月期","証券コード":"4526","会社名":"理研ビタミン(株)【4526】","会計方式":"日本方式","決算発表日":"2014年4月24日","決算月数":"12か月","売上高":"85,419百万円","営業利益":"5,027百万円","経常利益":"5,294百万円","当期利益":"3,590百万円","EPS（一株当たり利益）":"162.36円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"3,014.93円","総資産":"102,345百万円","自己資本":"66,667百万円","資本金":"2,537百万円","有利子負債":"12,123百万円","自己資本比率":"65.1%","ROA（総資産利益率）":"3.65%","ROE（自己資本利益率）":"5.66%","総資産経常利益率":"5.39%","日付":"2015-05-31T15:09:02.339Z"},{"_id":"5562fd3cee6e1634eb0601b6","決算期":"2013年3月期","証券コード":"4526","会社名":"理研ビタミン(株)【4526】","会計方式":"日本方式","決算発表日":"2013年4月25日","決算月数":"12か月","売上高":"77,568百万円","営業利益":"3,600百万円","経常利益":"3,741百万円","当期利益":"2,406百万円","EPS（一株当たり利益）":"106.65円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,722.51円","総資産":"94,257百万円","自己資本":"60,202百万円","資本金":"2,537百万円","有利子負債":"10,453百万円","自己資本比率":"63.9%","ROA（総資産利益率）":"2.66%","ROE（自己資本利益率）":"4.14%","総資産経常利益率":"4.14%","日付":"2015-05-31T15:09:02.339Z"}]